EP. 1: Characteristics and Complications of Crohn's Disease
EP. 2: Understanding the Pathophysiology of Crohn's Disease
EP. 3: Crohn's Disease: Differentiation and Diagnosis
EP. 4: Importance of Risk Assessment in Crohn's Disease
EP. 5: Therapeutic Approaches in Low-Risk Crohn's Disease
EP. 6: Approaches in Moderate- to High-Risk Crohn's Disease
EP. 7: Role of TNF-alpha Inhibitors in Crohn's Disease
EP. 8: Crohn's Disease: Measuring Therapeutic Response
EP. 9: When and How to Switch Therapies in Crohn's Disease
EP. 10: Targeting IL-12/IL-23 in Crohn's Disease
EP. 11: Crohn's Disease: Clinical Experience With Ustekinumab
EP. 12: Crohn's Disease: The Value of Treat-to-Target Therapy
EP. 13: Considerations for Upfront Therapy in Crohn's Disease
EP. 14: Crohn's Disease: Optimizing the Sequence of Therapies
EP. 15: Defining the Role of Surgery in Managing Crohn's Disease
EP. 16: Unmet Needs of Therapy for Crohn's Disease
EP. 17: Emerging Approaches and Novel Agents for Crohn's Disease
EP. 18: Crohn's Disease: Key Hopes and Understandings
EP. 19: ACG Crohn's Disease Guideline: NSAIDs & Diagnosis
EP. 20: Prescribing Aggressive Therapies & Specific Treatments
EP. 21: The Step-Up & Top-Down Approaches
EP. 22: Ustekinumab as the New Frontline Treatment
EP. 23: Current Advancements in Treatment, Obstacles & Goals
